Telomir Pharmaceuticals, Inc. Common Stock
TELO · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $1,266 | $1 | $1 | $0 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $130 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $58 | $304 | $47 | $0 |
| Total Curr. Assets | $1,324 | $435 | $49 | $0 |
| Property Plant & Equip (Net) | $0 | $0 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $55 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $4,339 | $0 | $0 |
| Total NC Assets | $0 | $4,339 | $0 | $55 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $1,324 | $4,774 | $49 | $55 |
| Liabilities | – | – | – | – |
| Payables | $588 | $707 | $404 | $19 |
| Short-Term Debt | $93 | $101 | $582 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $0 | $527 | $0 | $119 |
| Total Curr. Liab. | $681 | $1,336 | $986 | $138 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | -$0 | $0 |
| Total NC Liab. | $0 | $0 | -$0 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $681 | $1,336 | $986 | $138 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$30,597 | -$14,064 | -$992 | -$138 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $31,240 | $17,502 | $55 | $55 |
| Total Equity | $643 | $3,438 | -$937 | -$83 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $1,324 | $4,774 | $49 | $55 |
| Net Debt | -$1,173 | $100 | $580 | $0 |